search
Back to results

Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness

Primary Purpose

Tobacco Cessation

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
BecomeAnEX
Usual Care
Sponsored by
University of Maryland, Baltimore
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tobacco Cessation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18 or greater
  • Diagnosis of serious mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, or major depression)
  • Current smoker [prior to admission, smoked at least one cigarette or small cigar per day in the past month (unless restricted, e.g. due to ER/hospital visit) and smoked at least 100 cigarettes lifetime]
  • Interested in remaining quit after hospital discharge or quitting within the following 30 days
  • Expected Internet use at least 3 times/week post-discharge and ownership of mobile device with text messaging plan post-discharge.
  • Discharge destination within 1-hour of SPH given that Aim 3 involves biochemical verification (carbon monoxide testing).
  • Reading competence as demonstrated by a score of >= 37 on the Word Reading subtest of the Wide Range Achievement Test - 4th Edition (WRAT-4)168 to ensure the ability to engage in the intervention.

Exclusion Criteria:

  • Intellectual disability (DSM5 317, 318), traumatic brain injury, or deafness.
  • Homeless prior to admission or anticipated to be homeless at discharge.
  • Discharge to a residential setting where smoking is prohibited.
  • Medical condition for which the use of nicotine replacement therapy (NRT) is contraindicated including pregnant, planning to become pregnant, or breastfeeding; within 4 weeks post myocardial infarction; severe arrhythmia, severe angina pectoris; peptic ulcer; severe renal failure; poorly controlled insulin-dependent diabetes; severely uncontrolled hypertension; peripheral vascular disease.

Sites / Locations

  • Melanie BennettRecruiting
  • University of Maryland School of MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

BecomeAnEX

Usual Care

Arm Description

Participants will have three individual meetings with a research staff person while they are in the hospital. At these meetings participants will answer questions about their smoking and interest in quitting, learn about BecomeAnEx, and register with the BecomeAnEx program so that they can use it when you leave the hospital. Participants will be given two weeks of nicotine replacement therapy when they leave the hospital. Participants will be asked to use BecomeAnEx as much as they want when they leave the hospital.

Brief individual counseling, NRT during the hospital stay and a prescription for NRT at discharge (consistent with standard hospital procedures), and referral to the MD quitline.

Outcomes

Primary Outcome Measures

Feasibility of recruitment
Rate of recruitment
Feasibility of registration
Time to register with the web based intervention
Acceptability
Satisfaction with the web based intervention using the Services Satisfaction Questionnaire
Website utilization
Time on website
Smoking abstinence
Self-report 7-day point prevalence abstinence
Craving
Tobacco Cravings Questionnaire
Self-efficacy
Smoking Situations Confidence Questionnaire
Motivation to remain abstinent
Abstinence-Related Motivational Engagement Scale

Secondary Outcome Measures

Full Information

First Posted
April 26, 2020
Last Updated
September 25, 2023
Sponsor
University of Maryland, Baltimore
Collaborators
Sheppard Pratt Health System, Truth Initiative
search

1. Study Identification

Unique Protocol Identification Number
NCT04367506
Brief Title
Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness
Official Title
Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 1, 2021 (Actual)
Primary Completion Date
June 2024 (Anticipated)
Study Completion Date
June 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Maryland, Baltimore
Collaborators
Sheppard Pratt Health System, Truth Initiative

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
All patients with serious mental illness are abstinent while in the hospital for a psychiatric admission yet almost all return to smoking after discharge. The investigators propose to adapt a digital intervention both to the needs of SMI smokers and to being introduced in the inpatient psychiatric setting through a collaboration between experts in SMI and the Truth Initiative, a pre-eminent tobacco control organization. The investigators believe this will bridge the inpatient to outpatient gap in cessation services and will help people remain abstinent following hospital discharge.
Detailed Description
Persons with serious mental illness (SMI) die on average 10-15 years earlier than those in the general population. Smoking is the strongest risk factor for their elevated mortality. Helping SMI smokers to quit is an urgent and unmet need. The hospital is an optimal setting to provide smoking cessation services. Hospital admissions for SMI are common with more than 1.2 million inpatient stays for schizophrenia and mood disorders per year in the US. Hospitalized patients experience required abstinence, are available for counseling, and can try cessation medications in a supportive setting. The challenge is how to engage SMI patients in cessation services post-discharge. An easy-to-access digital intervention is a scalable and sustainable way to bridge the inpatient-to-outpatient gap and to promote sustained abstinence. Digital interventions can deliver all elements of cessation treatment and yield quit rates comparable to face to face and telephonic interventions. SMI patients use and benefit from technology-based interventions but currently there is no digital smoking cessation program addressing their needs. This R34 application will adapt a proven digital intervention, BecomeAnEX (EX), developed and run by Truth Initiative for over 10 years. Its core components are real-time one on one coaching via live chat, nicotine replacement therapy decision support and delivery, personalized quit plans, a large online social network for peer support, a robust and fully integrated text message program, and tailored email messaging. Adaptation will ensure that EX addresses the specific challenges of SMI smokers and is in line with principles of mental health recovery. In Aim 1 the investigators will develop and obtain preliminary feedback about EX-SMI, a version of EX adapted for SMI patients. A priori target mechanisms are motivation, abstinence self-efficacy, and cravings. In Aim 2 the investigators will conduct a one-arm pilot trial and obtain feedback from 20 SMI smokers recruited during psychiatric hospitalization and followed up at 2-weeks and 1-month post-discharge. Feasibility and acceptability will be assessed via participant feedback regarding their intervention experience, changes in motivation, self-efficacy and cravings, and automated tracking data on EX-SMI use post-discharge. In Aim 3, 90 SMI smokers recruited during psychiatric hospitalization will be randomized to usual care or to a revised version of EX-SMI and followed for 3 months after the hospital stay. The investigators will compare the feasibility/acceptability of EX-SMI, measure intervention impact on target mechanisms, and obtain initial estimates of efficacy on 7-day point prevalence abstinence. This pilot work directly addresses priorities of this RFA in refining and optimizing an efficacious intervention for a new target population. Ultimately, this program of research could have a powerful public health impact by increasing smoking cessation among persons with SMI.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tobacco Cessation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This project has three phases. Phase 1: Adapt BecomeAnEX, conduct usability testing (n=10), and train digital coaches. Phase 2: Conduct a 1-arm pilot trial of the adapted BecomeAnEX (n=20). Phase 3: Conduct a pilot randomized controlled trial (n=90) to examine indicators of feasibility, acceptability, target mechanisms, and preliminary efficacy.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
BecomeAnEX
Arm Type
Experimental
Arm Description
Participants will have three individual meetings with a research staff person while they are in the hospital. At these meetings participants will answer questions about their smoking and interest in quitting, learn about BecomeAnEx, and register with the BecomeAnEx program so that they can use it when you leave the hospital. Participants will be given two weeks of nicotine replacement therapy when they leave the hospital. Participants will be asked to use BecomeAnEx as much as they want when they leave the hospital.
Arm Title
Usual Care
Arm Type
Active Comparator
Arm Description
Brief individual counseling, NRT during the hospital stay and a prescription for NRT at discharge (consistent with standard hospital procedures), and referral to the MD quitline.
Intervention Type
Behavioral
Intervention Name(s)
BecomeAnEX
Intervention Description
This research study is focused on a smoking cessation program called BecomeAnEx. We are studying how to adapt BecomeAnEx for people with a mental health disorder who want to reduce or quit their tobacco smoking. BecomeAnEx includes a website that provides education about smoking and quitting. It also has a text messaging program that delivers personalized information. Persons in the program have access to real-time digital coaching with a remote coach who has experience helping people quit smoking. In addition, the program has an on-line community of current and former smokers that can provide support and encouragement.
Intervention Type
Behavioral
Intervention Name(s)
Usual Care
Intervention Description
Usual care represents what hospitalized psychiatric patients normally receive in terms of smoking cessation: brief individual counseling, NRT during the hospital stay and a prescription for NRT at discharge (consistent with standard hospital procedures), and referral to the MD quitline.
Primary Outcome Measure Information:
Title
Feasibility of recruitment
Description
Rate of recruitment
Time Frame
3 months
Title
Feasibility of registration
Description
Time to register with the web based intervention
Time Frame
3 months
Title
Acceptability
Description
Satisfaction with the web based intervention using the Services Satisfaction Questionnaire
Time Frame
3 months
Title
Website utilization
Description
Time on website
Time Frame
3 months
Title
Smoking abstinence
Description
Self-report 7-day point prevalence abstinence
Time Frame
3 months
Title
Craving
Description
Tobacco Cravings Questionnaire
Time Frame
3 months
Title
Self-efficacy
Description
Smoking Situations Confidence Questionnaire
Time Frame
3 months
Title
Motivation to remain abstinent
Description
Abstinence-Related Motivational Engagement Scale
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18 or greater Diagnosis of serious mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, or major depression) Current smoker [prior to admission, smoked at least one cigarette or small cigar per day in the past month (unless restricted, e.g. due to ER/hospital visit) and smoked at least 100 cigarettes lifetime] Interested in remaining quit after hospital discharge or quitting within the following 30 days Expected Internet use at least 3 times/week post-discharge and ownership of mobile device with text messaging plan post-discharge. Discharge destination within 1-hour of SPH given that Aim 3 involves biochemical verification (carbon monoxide testing). Reading competence as demonstrated by a score of >= 37 on the Word Reading subtest of the Wide Range Achievement Test - 4th Edition (WRAT-4)168 to ensure the ability to engage in the intervention. Exclusion Criteria: Intellectual disability (DSM5 317, 318), traumatic brain injury, or deafness. Homeless prior to admission or anticipated to be homeless at discharge. Discharge to a residential setting where smoking is prohibited. Medical condition for which the use of nicotine replacement therapy (NRT) is contraindicated including pregnant, planning to become pregnant, or breastfeeding; within 4 weeks post myocardial infarction; severe arrhythmia, severe angina pectoris; peptic ulcer; severe renal failure; poorly controlled insulin-dependent diabetes; severely uncontrolled hypertension; peripheral vascular disease.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Melanie Bennett, Ph.D.
Phone
410-706-2490
Email
mbennett@som.umaryland.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Brian Brandler
Phone
410-402-6425
Email
bbrandler@som.umaryland.edu
Facility Information:
Facility Name
Melanie Bennett
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21021
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Melanie Bennett
Phone
410-706-0892
Email
mbennett@som.umaryland.edu
Facility Name
University of Maryland School of Medicine
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21201
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Melanie E Bennett, Ph.D.
Phone
410-706-2490
Email
mbennett@som.umaryland.edu
First Name & Middle Initial & Last Name & Degree
Brian Brandler
Phone
410-402-6425
Email
bbrandler@som.umaryland.edu
First Name & Middle Initial & Last Name & Degree
Melanie Bennett, Ph.D.

12. IPD Sharing Statement

Learn more about this trial

Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness

We'll reach out to this number within 24 hrs